Skip to content
10-Q

Quarterly Report

Evolent Health, Inc. EVH

0001628908-25-000066

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 117.4M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $647.53M
Long Term Debt Q1 2025 · Dec 31, 2024 $490.52M
Short Term Debt Q1 2025 · Mar 31, 2025 $171.79M
Short Term Debt Q1 2025 · Dec 31, 2024 $171.47M
Current Liabilities Q1 2025 · Mar 31, 2025 $739.1M
Current Liabilities Q1 2025 · Dec 31, 2024 $715.5M
Total Liabilities Q1 2025 · Mar 31, 2025 $1.52B
Total Liabilities Q1 2025 · Dec 31, 2024 $1.35B
Current Assets Q1 2025 · Mar 31, 2025 $727.93M
Current Assets Q1 2025 · Dec 31, 2024 $607.12M
Total Assets Q1 2025 · Mar 31, 2025 $2.65B
Total Assets Q1 2025 · Dec 31, 2024 $2.54B
Cash And Equivalents Q1 2025 · Dec 31, 2024 $104.2M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $165.15M
Shares Diluted Q1 2025 · Mar 31, 2024 114.14M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 $4.91M
Stockholders Equity Q1 2025 · Mar 31, 2024 $1.05B
Stockholders Equity Q1 2025 · Dec 31, 2023 $1.07B
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.22
Eps Basic Q1 2025 · Mar 31, 2024 −$0.22
Sga Expense Q1 2025 · Mar 31, 2024 $79.1M
Net Income Q1 2025 · Mar 31, 2024 −$17.28M
Operating Income Q1 2025 · Mar 31, 2024 −$13.41M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $535.55M
Revenue Q1 2025 · Mar 31, 2024 $639.65M